Self evaluation of side-effects of patients treated sequentially with sunitinib and sorafenib in kidney cancer

被引:0
|
作者
Plantade, A. [1 ]
Leborgne, S. [1 ]
Massard, C. [1 ]
Fizazi, K. [1 ]
Escudier, B. [1 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
来源
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词
D O I
10.1016/S1359-6349(07)71156-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4525
引用
收藏
页码:306 / 306
页数:1
相关论文
共 50 条
  • [21] Comments on the Article "Cutaneous Side effects of the Multikinase inhibitors Sorafenib and Sunitinib"
    Wolf, G.
    HAUTARZT, 2011, 62 (07): : 560 - 560
  • [22] Incidence of Thyroid Hormone Therapy in Patients Treated with Sorafenib or Sunitinib
    Schuessel, Katrin
    Feldt, Sandra
    Quinzler, Renate
    Czeche, Sittah
    Franzmann, Alexandra
    Ludwig, Wolf-Dieter
    Schulz, Martin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S259 - S259
  • [23] Side-effects in women treated with adjuvant endocrine therapy for breast cancer
    Rademaker, L. M.
    Gal, R.
    May, A. M.
    Batenburg, M. C. T.
    van der Leij, F.
    Bijlsma, R. M.
    Verkooijen, H. M.
    Doeksen, A.
    Ernst, M. F.
    Evers, D. J.
    van der Pol, C. C.
    Monninkhof, E. M.
    BREAST, 2025, 80
  • [24] Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib
    Herrmann, Edwin
    Gerss, Joachim
    Bierer, Stefan
    Koepke, Thomas
    Bolenz, Christian
    Hertle, Lothar
    Wuelfing, Christian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (01) : 61 - 67
  • [25] Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib
    Edwin Herrmann
    Joachim Gerss
    Stefan Bierer
    Thomas Köpke
    Christian Bolenz
    Lothar Hertle
    Christian Wülfing
    Journal of Cancer Research and Clinical Oncology, 2009, 135
  • [26] Management of side-effects of targeted therapies in renal cancer: cardiovascular side-effects
    Ederhy, Stephane
    Duclos, Brigitte
    Mahammedi, Hakim
    Doublet, Jean-Dominique
    BULLETIN DU CANCER, 2011, 98 : S19 - S34
  • [27] Management of side-effects of targeted therapies in renal cancer: gastrointestinal side-effects
    Davin, Jean-Louis
    Ducrotte, Philippe
    Houede, Nadine
    BULLETIN DU CANCER, 2011, 98 : S69 - S78
  • [28] Hypogonadism in male cancer patients treated with the tyrosine kinase inhibitors sunitinib (SUN) or sorafenib (SOR)
    Wolter, P.
    Wildiers, H.
    Vanderschueren, D.
    Dumez, H.
    Clement, P.
    Schoffski, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] SIDE-EFFECTS OF CAPTOPRIL IN HYPERTENSIVE PATIENTS WITH VARIOUS GRADES OF KIDNEY DYSFUNCTION
    ONOYAMA, K
    HIRAKATA, H
    ABE, I
    TAKISHITA, S
    OMAE, T
    FUJISHIMA, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 40 (02): : 333 - 336
  • [30] SERUM NEUROLEPTIC LEVELS AND EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS TREATED WITH AMOXAPINE
    GAFFNEY, GR
    TUNE, LE
    JOURNAL OF CLINICAL PSYCHIATRY, 1985, 46 (10) : 428 - 429